Hoffman, V, Hallas, J, Linder, M, Margulis, A, Suehs, B T, Arana, A, Phiri, K, Enger, C, Horter, L, Odsbu, I, Olesen, M, Perez-Gutthann, S, Xu, Y, Kristiansen, N S, Appenteng, K, de Vogel, S, Seeger, J D & the mirabegron PMR-PASS study group 2021, ' Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder : Findings from a Non-Interventional, Multinational, Cohort Study ', Drug Safety, vol. 44, no. 8, pp. 899-915 . https://doi.org/10.1007/s40264-021-01095-7 Drug Safety
Phiri, K, Hallas, J, Linder, M, Margulis, A, Suehs, B, Arana, A, Bahmanyar, S, Hoffman, V, Enger, C, Horter, L, Odsbu, I, Olesen, M, Perez-Gutthann, S, Kristiansen, N S, Appenteng, K, de Vogel, S & Seeger, J 2021, ' A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder ', Current Medical Research and Opinion, vol. 37, no. 5, pp. 867-877 . https://doi.org/10.1080/03007995.2021.1891035 the Mirabegron PMR-PASS study group 2021, ' A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder ', Current Medical Research and Opinion . https://doi.org/10.1080/03007995.2021.1891035
Arana, A, Pottegard, A, Kuiper, J G, Crellin, E, Reutfors, J, Schmitt-Egenolf, M, Lund, L C, Houben, E, Booth, H, Calingaert, B, Kaye, J A, Gembert, K, Rothman, K J, Dedman, D, Kieler, H, Gutierrez, L, Hallas, J & Perez-Gutthann, S 2020, ' To what extent are topical tacrolimus or pimecrolimus associated with increased risk of skin cancer and lymphoma? Longterm results from Joelle study ', Pharmacoepidemiology and Drug Safety, vol. 29, no. Suppl. 3, 3702, pp. 568-569 . < https://doi.org/10.1002/pds.5114 > University of Southern Denmark